Mettler-Toledo International, Inc.

MTD Healthcare Diagnostics & Research

Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.

Revenue
+6.27%
EPS
+16.2%
Free cash flow
+33.0%
Total debt
−8.42%

Quarter to September 2026, against a year earlier

1,742.04 62.96 +3.75%
Market cap
$33.6B
P/E
37.7×
Fwd P/E
36.1×
Dividend yield
—
F-score
5/9
Altman Z
10.23
Beneish M
−2.44
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 6 Nov
P/E ratio

+8 more quarters

33.01 29.50 28.68 32.66
P/S ratio
7.14 6.26 6.22 7.18
P/FCF ratio
33.86 32.23 29.75 34.55
P/Operating CF
127.38 183.02 82.81 97.76
P/B ratio
0.00 0.00 2,004.62 388.41
EV/Sales
7.65 6.79 6.72 7.65
EV/EBITDA
24.77 22.13 21.27 24.62
EV/FCF
36.32 34.96 32.14 36.80
Current Ratio
1.14 1.20 1.12 1.10
Net Debt/EBITDA
5.54 8.36 5.93 0.00
Debt/Equity
(91.05) (53.21) 164.70 26.06
Earnings Yield
3.03% 3.39% 3.49% 3.06%
Free Cash Flow Yield
2.95% 3.10% 3.36% 2.89%
Free Cash Flow per Share
8.93 6.03 14.05 15.46
Book value per Share
(1.15) (2.06) 0.64 3.89
Free Cash Flow
184.08 122.38 282.62 308.57
EV/EBIT
27.55 24.66 23.65 27.37
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026